A panel discussion with:
Bringing cell & gene therapies to market is no easy feat. The many technicalities involved in running trials, scaling manufacturing capabilities, market access and launch drives up end-to-end costs, meaning patients are often faced with a complex, long and expensive road to treatment.
With the aim to bring CGT’s to as many patients as possible, panellists discuss the early-commercial planning factors facing CGT companies today and tried-and-tested solutions.
Watch now
In partnership with
Inizio unlocks the value of your healthcare innovation by connecting best-in-class strategic, analytic, and creative capabilities. By bridging our scientific knowledge, market intelligence, actionable data, cutting-edge technology, and creative execution, Inizio is by your side to help you confidently navigate the complex asset lifecycle, rising to any challenges together.
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd